Mr. Ning Min joined Legend in 1991 and currently serves as Chairman of Board of Directors at Legend Holdings Corporation.Mr. Ning Min has been a Member of the Executive Committee and CFO of Legend Holdings for a long time. He is in full charge of the finance and funds, risk control and auditing, capital market as well as public relations, and oversees the financial investments business. He plays an important role in formulating the corporate strategy, business development, and organization construction. Mr. Ning Min is also the Director of Legend Star, Legend Capital, Hony Capital, Legend Star, EAL, Joyvio Group, and Levima Advanced Materials.Mr. Ning has served successively as Assistant to the President, Assistant President & Secretary of Board, Vice President, Senior Vice President & Chief Financial Officer, Executive Director, and is now Chairman of Board of Directors in Legend Holdings.He has a bachelor's degree in economics from Renmin University of China.

Mr. Wang holds an international MBA degree from Tsinghua University. He is currently the General Manager and Managing Partner of Legend Star, and serves as Chairman of Legend Star Union, fully responsible for investment, incubation and overall operational business. He has 20 years of experience in the venture capital field and was previously senior Vice President of Zero2IPO Group and the partner of Jiufan Investment. Mr. Wang joined Legend Star in 2010. His investment in iDreamSky has become a classic case that got listed on NASDAQ after only three years of angel investment, and generating a nearly 100-fold return. He served as the General Manager and Managing Partner of Legend Star since 2015, and promoted the system layout of Legend Star in cutting-edge technology, medical health and TMT, making Legend Star consistently ranked among the top early stage investment institutions in China every year, and creating an excellent investment portfolio including Megvii, Aispeech, Pony.ai, Burning Rock, Kintor Pharmaceutical and other star projects. Since 2014, Mr. Wang has been continuously selected as one of the "Top 10 Early Stage Investors in China" by Zero2IPO and ChinaVenture, and as one of the "Top 30 Most Influential Investors in China" by Fortune in 2014 and 2018.

Mr. Lu joined Legend Star at the end of 2009, and responsible for establishing its angel investment business as a partner of Legend Star. Currently, he is responsible for investments in health care, particularly in fields of innovative medicine, biological and genetic technology, innovative medical service and other fields. The investment cases include Kintor, PEGBIO, Burning Rock(NASDAQ：BNR), Axonics (NASDAQ:AXNX), Conmedbio, HiFiBiO, MNCHIP, Coyote, Deepwise, etc.

Mr. Leng joined Legend Star in 2013, has been committed to angel investment in health care, especially biological medicine, molecular diagnosis and gene sequencing, tumor immunology and cell therapy, medical-grade sensors, and data collection terminals. Mr. Leng has made over 20 investment cases in these sectors, including Burning Rock, PegBio, Ribobio, Percans Oncology, MEDATC, iGeneTech, GeneDock, Coyote Bioscience. Mr. Leng has worked in the medical care industry for 13 years, and another 6 years in pharmaceutical industrial M&As. He received a Master’s Degree of the School Economics and Management, Tsinghua University, and a Bachelor’s Degree of the School of Life Sciences, Xiamen University.

Mr. Gao joined Legend Star in 2016, currently responsible for the investment and management of cutting-edge technologies, focusing on AI, robotics, autonomous driving, optoelectronic chips, etc. Early investment cases of cutting-edge technology led by him include: Pony.ai,Light theto,CiDi,HAI ROBOTICS,ADAPS PHOTONICS,Tsintel Technology (acquired by Weichai Power),MYSEC,Jikeguanghe and more than 20 other cases. He graduated from Beijing University of Technology with a bachelor's degree and Columbia University with a master's degree. He has ten years of investment experience in the field of science and technology in the primary market, and has worked in overseas investment banks, RMB PE funds, and the war investment department of listed companies. He was awarded 36 Kr "36 Great Investors Under the Age of 36 in 2019" and Jazzyear "China's Most Insighted Technology Investor in 2019" and many other awards.